National Family Health History Day: CGT Advancements for Generational Health
Since 2004, Thanksgiving Day in the U.S. has been paired with another lesser known but equally family-centric celebration – National Family Health History Day. Like Thanksgiving, National Family Health History Day shares the importance of caring about yourself by investing in those you love.
Cryoport Systems is a proud advocate for celebrating holidays that emphasize the health and wellbeing of the world’s population. We recognize National Family Health History Day as an important opportunity to understand generational health and want to point to our clients’ recent medical innovations within the cell and gene therapy landscape that help keep families healthy and together for years to come.
The Meaning Behind the Holiday
National Family Health History Day was first established by the U.S. Surgeon General to encourage families to discuss and document their health histories.1 It was paired with Thanksgiving Day to encourage opportunities to facilitate conversations about generational health since many families gather in-person on November 28th. As numerous health conditions, such as heart disease, diabetes, and cancer, have genetic factors, understanding family medical history can be crucial for preventive care and early detection. This day emphasizes how discussing health history can lead to better health outcomes for future generations. Families are encouraged to share health-related stories and information to build a clearer picture of risks and tendencies in their shared lines.
Client Innovation for Generational Health
Cell and gene therapies (CGTs) can be used to treat an increasing number of diseases. Particularly, patients suffering from illnesses such as cancer, neurological disorders, and other genetic diseases have experienced successful recoveries because of innovations within the CGT market. Our clients that support the treatment of disorders with advanced CGTs have made waves this past year with cutting-edge products and therapies that give hope to patients against all odds. Examples of these client innovations include:
- Bristol Meyers Squibb – FDA accelerated approval of Breyanzi, the first CAR T cell therapy available for relapsed or refractory chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL)
- Iovance Biotherapeutics, Inc. FDA commercial approval for their therapy for advanced melanoma, AMTAGVI™ (lifileucel)
- ImmunityBio, Inc. – FDA approval for ANKTIVA®, a treatment for BCG-unresponsive non-muscle invasive bladder cancer
- Adaptimmune – FDA accelerated approval of TECELRA® (afamitresgene autoleucel), the first engineered cell therapy for a solid tumor cancer approved in the U.S.
These clients and others give hope to families battling disorders of all types with their new medicine. Diseases that once were untreatable now can be met head-on with today’s due to these organizations’ dedication.
Cryoport Systems’ Support of the CGT Market
Cryoport Systems is proud to Enable the Outcome™ for clients focused on making the world a healthier place. Our platform of supply chain solutions can be leveraged throughout the entire supply chain, and our global reach connects clients with their patients anywhere in the world. With our support, organizations can leverage:
- Logistics capabilities – transport services that spans secure Shipping Systems to last mile delivery
- BioServices and biostorage – the secure management of research and manufacturing materials for cell and gene therapies
- Cryopreservation – optimizing leukapheresis-derived cell therapies by enhancing the safety, quality, and viability of manufacture-ready cryopreserved leukopaks with IntegriCell™
- Consulting Services – expert guidance and customized solutions for life sciences logistics excellence
The culmination of our services creates a single-partner approach that negates multiple vendors throughout the supply chain. This simplifies the management process and allows our clients to focus on what truly matters – the waiting patient.
This National Family Health History Day, share the importance of generational health by connecting with your loved one’s health history. For more information on how Cryoport Systems Enables the Outcome™ for clients researching, developing, and manufacturing today’s most innovative products, reach out to us on our website.
Resources & Further Reading